{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T21:22:04Z","timestamp":1770153724743,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.micpath.2021.104740","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T08:37:21Z","timestamp":1610699841000},"page":"104740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Sofosbuvir plus ribavirin combination regimen boost liver functions and antioxidant profile in hepatitis C virus patients"],"prefix":"10.1016","volume":"150","author":[{"given":"Omayma A.","family":"Ragab AboZaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed K.","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omneia M.","family":"Abdel hammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel","family":"Maksoud H.A","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali W.","family":"Elwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omneia Elsaid","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed G.","family":"Elharrif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104740_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4236\/ojim.2011.12010","article-title":"Impact of past HBV exposure on virological response to combined interferon ribavirin therapy in patients with chronic HCV genotype 4","volume":"1","author":"Said","year":"2011","journal-title":"Open J. Intern. Med."},{"key":"10.1016\/j.micpath.2021.104740_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00423-010-0643-0","article-title":"Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver","volume":"395","author":"Abdel-wahab","year":"2010","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.micpath.2021.104740_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cld.2009.11.007","article-title":"Management of acute hepatitis C","volume":"14","author":"Maheshwari","year":"2010","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.micpath.2021.104740_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2021.104740_bib5","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1245\/s10434-010-1540-z","article-title":"Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver","volume":"18","author":"Li","year":"2011","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.micpath.2021.104740_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.mcg.0000155517.02468.46","article-title":"Mitochondrial dysfunction in hepatitis C","volume":"39","author":"Korenaga","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.micpath.2021.104740_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4254\/wjh.v8.i3.183","article-title":"Sofosbuvir treatment and hepatitis C virus infection","volume":"8","author":"Nakamura","year":"2016","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.micpath.2021.104740_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0009-8981(78)90081-5","article-title":"Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method","volume":"90","author":"Satoh","year":"1978","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.micpath.2021.104740_bib9","first-page":"158","article-title":"Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase","volume":"70","author":"Paglia","year":"1967","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.micpath.2021.104740_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.micpath.2021.104740_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0006-291X(72)80218-3","article-title":"The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen","volume":"46","author":"Nishikimi","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2021.104740_bib12","first-page":"718","article-title":"IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 C. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase","volume":"40","author":"Schumann","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.micpath.2021.104740_bib13","first-page":"725","article-title":"IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 C. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase","volume":"40","author":"Schumann","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.micpath.2021.104740_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0044-8486(91)90205-L","article-title":"Changes with different diets in plasma enzymes (GOT, GPT, LDH, ALP) and plasma lipids (cholesterol, triglycerides) of sea-bass (Dicentrarchus labrax)","volume":"93","author":"Lemaire","year":"1991","journal-title":"Aquaculture"},{"key":"10.1016\/j.micpath.2021.104740_bib15","series-title":"Clinical Chemistry, Principles and Technics","first-page":"190","author":"Henry","year":"1964"},{"key":"10.1016\/j.micpath.2021.104740_bib16","series-title":"Clinical Chemistry, Theory, Analysis, and Correlation","first-page":"1316","article-title":"Total serum protein","author":"Koller","year":"1984"},{"key":"10.1016\/j.micpath.2021.104740_bib17","series-title":"Bilirubin\" Clin. Chem","first-page":"1238","author":"Kaplan","year":"1984"},{"key":"10.1016\/j.micpath.2021.104740_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0076-6879(80)70067-8","article-title":"Enzyme immunoassay ELISA and EMIT","volume":"70","author":"Engvall","year":"1980","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.micpath.2021.104740_bib19","unstructured":"M. S. Farias, P. Budni, C. M. Ribeiro, E. B Parisotto, C. E Santos, J. F. Dias, et al., Antioxidant Supplementation Attenuates Oxidative Stress."},{"key":"10.1016\/j.micpath.2021.104740_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1023\/A:1022909127992","article-title":"LPO and free-radical oxidation parameters in patients with acute viral hepatitis","volume":"134","author":"Nagoev","year":"2002","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.micpath.2021.104740_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/156652411795976592","article-title":"Hepatitis C virus, oxidative stress and steatosis: current status and perspectives","volume":"11","author":"Gonz\u00e1lez-Gallego","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.micpath.2021.104740_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1743-422X-8-155","article-title":"S., Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis","volume":"8","author":"Jahan","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.micpath.2021.104740_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1155\/2003\/710693","article-title":"Oxidative stress in chronic hepatitis C: the effect of interferon therapy and correlation with pathological features","volume":"17","author":"Serejo","year":"2003","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.micpath.2021.104740_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2015.04.023","article-title":"Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genome 4","volume":"63","author":"Doss","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.micpath.2021.104740_bib25","first-page":"218A","article-title":"Effects of Sustained Virological Response (SVR) on the risk of liver transplant, hepatocellular carcinoma, death and re-infection: meta-analysis of 129 studies in 23,309 patients with Hepatitis C infection","volume":"60","author":"Hill","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2021.104740_bib26","series-title":"Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study,\u201d Interdisciplinary Perspectives on Infectious Diseases","author":"Hanan","year":"2019"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:39:13Z","timestamp":1760110753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":26,"alternative-id":["S0882401021000127"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104740","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sofosbuvir plus ribavirin combination regimen boost liver functions and antioxidant profile in hepatitis C virus patients","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104740"}}